. 2014 Oct 10;39(12):2313–2318. doi: 10.1007/s11064-014-1402-3

Table 2.

ADH and ALDH activity in the sera of patients with brain tumour

Tested group	ADH I	ADH II	ADH III	ADH IV	ADH Total	ALDH
	Median	Median	Median	Median	Median	Median
	Range	Range	Range	Range	Range	Range
	Range	Mean	Mean	Mean	Mean	Mean
Brain cancer (n = 62)	1.77	14.81	12.23	5.46	895	2.90
	1.08–3.64	6.94–21.65	7.05–18.21	2.11–11.98	338–1,544	1.35–5.63
	1.73	14.24	12.16	5.31	866	2.77
Glioblastoma (n = 36)	1.79	14.96	12.55	5.64	924	3.02
	1.11–3.64	7.25–21.65	7.62–18.21	2.36–11.98	366–1,544	1.48–5.63
	1.76	14.55	12.33	5.40	901	2.88
Meningioma (n = 26)	1.73	14.52	12.14	5.32	880	2.84
	1.08–3.32	7.25–20.48	7.05–18.03	2.11–11.56	338–1,488	1.35–5.14
	1.71	14.18	12.05	5.21	856	2.68
Control (n = 120)	1.35	14.45	11.96	5.22	664	2.74
	0.96–2.83	6.06–19.82	7.22–17.48	2.04–11.75	267–1,345	1.21–5.36
	1.31	14.02	11.35	5.08	740	2.58
	p^a < 0.001*	p^a = 0.327	p^a = 0.296	p^a = 0.436	p^a < 0.001*	p^a = 0.274
	p^b < 0.001*	p^b = 0.366	p^b = 0.346	p^b = 0.372	p^b < 0.001*	p^b = 0.369
	p^c < 0.001*	p^c = 0.258	p^c = 0.377	p^c = 0.348	p^c < 0.001*	p^c = 0.361
	p^d = 0.437	p^d = 0.436	p^d = 0.281	p^d = 0.274	p^d = 0.423	p^d = 0.285

Data are expressed as mU/l

p ^a brain cancer versus control

p ^b glioblastoma versus control

p ^c meningioma versus control

p ^d glioblastoma versus meningioma

* statistically significant differences between suitable groups